𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thyroid carcinoma after radioactive iodine therapy for Graves' disease

✍ Scribed by Osamu Ozaki; Kunihiko Ito; Takashi Mimura; Kiminori Sugino; Yutaka Kitamura; Hiroshi Iwabuchi; Michikazu Kawano


Publisher
Springer
Year
1994
Tongue
English
Weight
447 KB
Volume
18
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.

✦ Synopsis


Although the causal relation between radioactive iodine therapy (RIT) for Graves' disease and the subsequent occurrence of thyroid carcinoma is not definite, surgeons may be faced with the treatment of such patients. We studied the dinicopathoiogic features of patients with thyroid carcinoma following RIT for Graves' disease. From January 1983 to December 1991, 11 patients with thyroid carcinoma occurring 1 year or more after RIT for Graves' disease underwent surgery at Ito Hospital. These 11 patients accounted for 0.51% of 2146 surgical cases of thyroid carcinoma and 0.17% of 6419 RIT cases of Graves' disease during the period. They were all women, and their mean ages at RIT and surgery were 44.3 and 51.4 years, respectively. The administered dose of RI was 222.1 MBq and the absorbed dose 45.3 Gy on average. Total thyroidectomy was performed in two patients, subtotal thyroidectomy in three, and iobectomy in six. Bilateral modified neck dissection (MND) was added in two patients, and ipsilateral MND in seven. Histology revealed l0 papillary and 1 follicular carcinoma. The mean diameter of the tumor was 18.5 mm. Intraglandular dissemination of the tumor was noted in only one case and solid growth pattern in two. Nodal metastasis was disclosed in six cases, but in five of them only one node was involved. The present study indicated that thyroid carcinoma occurring after RIT for Graves' disease is not an aggressive variety, and thyroid lobectomy with ipsilateral MND would be sufficient as surgical treatment for such patients.

During the 1950s thyroid carcinoma was experimentally induced in the rat by radioactive iodine (RI) administration [1-3], and cases of thyroid carcinoma following RI therapy for Graves' disease have been reported [4][5][6]. Although the causal relation between RI therapy for Graves' disease and the subsequent occurrence of thyroid carcinoma is questioned by many authors [7-9], patients with thyroid carcinoma following RI therapy for Graves' disease are occasionally seen in clinical practice. The extent of surgery, however, has not been well established. We studied the clinicopathologic features and the extent of surgical treatment in such patients.


πŸ“œ SIMILAR VOLUMES


Clinical outcome of patients with papill
✍ Rena Vassilopoulou-Sellin; Pamela N. Schultz; Thomas P. Haynie πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 889 KB

BACKGROUND. Among patients with well differentiated papillary thyroid carcinoma who generally have an excellent prognosis and a near-normal lifespan, there exist subsets of patients who have significant risk for morbidity and mortality from this disease. It is important to define the patterns of dis

Prognostic value of postsurgical stimula
✍ Anna M. Sawka; Steven Orlov; Jacob Gelberg; Barry Stork; Mark Dowar; Michael Sha πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 174 KB πŸ‘ 1 views

## Abstract ## Background. In well‐differentiated thyroid carcinoma, predictors of future positivity of stimulated thyroglobulin (>2 ΞΌg/L) after initial radioactive iodine treatment are not known. ## Methods. In a retrospective study, we used logistic regression analysis to determine whether pos

Retrospective evaluation of the dose rec
✍ Mireille Izembart; Jean Chavaudra; Bernard Aubert; Gabriel VallΓ©e' πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 397 KB

In an earlier study, we evaluated the frequency of clinical manifestations of ovarian insufficiency after radioiodine therapy for thyroid cancer. We were thus led to consider the dose received by the ovary (DRO) during these treatments. In the literature, this dose is expressed as a function of the

Postoperative radioactive iodine evaluat
✍ Dr. Joseph N. Attie; George Bock; Dr. Gerard W. Moskowitz; Dr. Donald Margouleff πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 515 KB

The records of 430 patients who underwent total thyroidectomy with radioactive iodine (RAI) uptake studies performed postoperatively were reviewed. Indications for the administration of an ablative dose of iodine 131 are given. The majority (85.4%) had no or low (less than 2%) evidence of focal upta